Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Bronchopulmonary Sequestration D001998 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Varicose Veins D014648 7 associated lipids
Tachycardia, Paroxysmal D013614 2 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Macular Edema D008269 3 associated lipids
Aortic Rupture D001019 3 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Diseases in Twins D004200 4 associated lipids
Pulmonary Heart Disease D011660 2 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Hänsch GM et al. Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid. 1985 J. Immunol. pmid:2409145
Fiedler VB et al. Leukotrienes on porcine hemodynamics and prostanoid release. 1985 Int. J. Cardiol. pmid:2993176
Heinz TR et al. Radiation-induced alterations in cyclooxygenase product synthesis by isolated perfused rat lungs. 1985 Prog Biochem Pharmacol pmid:3921980
Lauri D et al. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. 1985 J. Lab. Clin. Med. pmid:3923145
Johnson A and Malik AB Pulmonary transvascular fluid and protein exchange after thrombin-induced microembolism. Differential effects of cyclooxygenase inhibitors. 1985 Am. Rev. Respir. Dis. pmid:3925828
Powell AM et al. Menstrual-PGF2 alpha, PGE2 and TXA2 in normal and dysmenorrheic women and their temporal relationship to dysmenorrhea. 1985 Prostaglandins pmid:3856904
Packham MA et al. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin. 1985 Blood pmid:3926022
Cattaneo M et al. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. 1985 Thromb. Haemost. pmid:3927505
Aitokallio-Tallberg A et al. Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. 1985 Br. J. Cancer pmid:2986666
Callahan KS et al. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets. 1985 Circulation pmid:2986877
Glance DG et al. Prostaglandin production and stimulation by angiotensin II in the isolated perfused human placental cotyledon. 1985 Am. J. Obstet. Gynecol. pmid:3855602
Apprill P et al. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. 1985 Circulation pmid:2988822
Mehta J and Mehta P Prostacyclin and thromboxane A2 production by human cardiac atrial tissues. 1985 Am. Heart J. pmid:3880988
Friedrich T et al. Follow-up of prostaglandin plasma levels after acute myocardial infarction. 1985 Am. Heart J. pmid:3880994
Wilson TW and Tan LK Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion. 1985 Diabetes pmid:3881302
Longenecker GL et al. Kinetics of ibuprofen effect on platelet and endothelial prostanoid release. 1985 Clin. Pharmacol. Ther. pmid:3882308
Howes EL et al. Lipopolysaccharide tolerance inhibits eye inflammation. I. Reduced immune complex or lipopolysaccharide effects. 1985 Arch. Ophthalmol. pmid:3156578
Addonizio VP et al. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation. 1985 J. Thorac. Cardiovasc. Surg. pmid:2582210
Kuzuya T et al. Determination of plasma thromboxane B2 by radioimmunoassay: methodological problems and accuracy. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2936210
Morita I et al. Effect of dietary protein level on platelet aggregation in rat. 1985 Prostaglandins Leukot Med pmid:3892545
de Lorgeril M et al. Acute influence of cigarette smoke in platelets, catecholamines and neurophysins in the normal conditions of daily life. 1985 Eur. Heart J. pmid:2937635
Lelcuk S et al. Prostacyclin and thromboxane A2 moderate postischemic renal failure. 1985 Surgery pmid:3895535
Paajanen H and Kormano M Prostacyclin (PGI2) and thromboxane (TXA2) levels during intravenous contrast medium administration in CT. 1985 Eur J Radiol pmid:3896802
Yui Y et al. A new stable prostacyclin analogue OP41483 (15-cyclopentyl-omega-pentanor-5(E)-carbacyclin). 1985 Jpn. Circ. J. pmid:3897597
Higashihara M et al. A monoclonal anti-human platelet antibody: a new platelet aggregating substance. 1985 Blood pmid:3967086
Nawroth PP et al. Thromboxane production by perturbed bovine aortic endothelial cells in culture. 1985 Blut pmid:3967102
Martin JL et al. Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia. 1985 J. Am. Coll. Cardiol. pmid:3968305
De Caterina R et al. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. 1985 Thromb. Res. pmid:3975876
Cook JA et al. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia. 1985 Circ. Shock pmid:3978769
Westenfelder C et al. Renal function in calves with total artificial hearts. 1985 Trans Am Soc Artif Intern Organs pmid:3837477
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Schrör K et al. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. 1985 Klin. Wochenschr. pmid:3838352
Bult H et al. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid. 1985 Br. J. Pharmacol. pmid:3838489
Yamaguchi A et al. Effect of cetiedil on platelet aggregation and thromboxane synthesis. 1985 Thromb. Res. pmid:2986312
Elliott GR et al. Differential regulation of the cyclooxygenase pathway in starch elicited rat peritoneal macrophages by prostaglandin E2, U-44069, a stable endoperoxide analogue and dibutyryl-cyclic AMP. 1985 Eur. J. Pharmacol. pmid:2995076
Remuzzi G et al. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. 1985 J. Clin. Invest. pmid:4038407
Mogensen F et al. Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test. 1985 Thromb. Res. pmid:4038824
Tada M et al. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction. 1985 Int. J. Cardiol. pmid:4040500
Lorenzana RM et al. Experimental T-2 toxicosis in swine. I. Changes in cardiac output, aortic mean pressure, catecholamines, 6-keto-PGF1 alpha, thromboxane B2, and acid-base parameters. 1985 Fundam Appl Toxicol pmid:3840756
Wargovich T et al. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. 1985 J. Am. Coll. Cardiol. pmid:4045029
Feuerstein G et al. Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. 1985 Circ. Shock pmid:3841032
Cerletti C et al. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". 1985 Thromb. Haemost. pmid:4049312
Dejana E et al. Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy. 1985 Proc. Soc. Exp. Biol. Med. pmid:3841210
Fiedler VB et al. The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury. 1985 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3841382
Singer P et al. Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. 1985 Atherosclerosis pmid:3000395
Miura K et al. Effect of SA-446, an angiotensin-converting enzyme inhibitor, on renal function in anesthetized dogs: special reference to arachidonic acid metabolites. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580127
Olanoff LS et al. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580129
Hook BG et al. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis. 1985 Jan-Feb J. Cardiovasc. Pharmacol. pmid:2580139
Fisher M and Zipser R Increased excretion of immunoreactive thromboxane B2 in cerebral ischemia. 1985 Jan-Feb Stroke pmid:3966251
Mullane KM and McGiff JC Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anesthetized dogs. 1985 Jul-Aug J. Cardiovasc. Pharmacol. pmid:2410715
Uyama O et al. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. 1985 Mar-Apr Stroke pmid:3883580
Fujimoto T et al. Cerebrovascular injuries induced by activation of platelets in vivo. 1985 Mar-Apr Stroke pmid:3975962
Lamy M et al. Biochemical pathways of acute lung injury. 1985 May-Jun Bull Eur Physiopathol Respir pmid:3873973
Jolly SR et al. Platelet depletion in experimental myocardial infarction. 1985 May-Jun Basic Res. Cardiol. pmid:4026785
Hillbom M et al. Effects of ethanol on platelet function. 1985 May-Jun Alcohol pmid:4026960
Codde JP et al. Changes in prostanoid synthesis in response to diet and hypertension in one-kidney, one clip rats. 1985 Nov-Dec Hypertension pmid:3908314
Nagatsuka K et al. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin. 1985 Sep-Oct Stroke pmid:3931302
Pfliegler G et al. Platelet function studies in myeloproliferative disorders. 1986 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2435631
Rimola A et al. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). 1986 J. Hepatol. pmid:3462243
Cunnane SC et al. n-3 Essential fatty acids decrease weight gain in genetically obese mice. 1986 Br. J. Nutr. pmid:3676212
Hsu CY et al. Increased thromboxane level in experimental spinal cord injury. 1986 J. Neurol. Sci. pmid:3525758
Slotman GJ et al. Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. 1986 Surgery pmid:3526603
Lihrmann I et al. Role of prostaglandins in calcium-induced corticosteroid secretion by isolated frog interrenal gland. 1986 Prostaglandins pmid:3464040
Scharschmidt LA et al. Angiotensin II and eicosanoids in the control of glomerular size in the rat and human. 1986 Am. J. Physiol. pmid:2936254
Wang Z et al. [Preliminary report on the application of thromboxane B2 radioimmunoassay]. 1986 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:2953485
Ali M and Mohammed SY Selective suppression of platelet thromboxane formation with sparing of vascular prostacyclin synthesis by aqueous extract of garlic in rabbits. 1986 Prostaglandins Leukot Med pmid:3547414
Peters SP et al. Mediator release from human lung under conditions of reduced oxygen tension. 1986 J. Pharmacol. Exp. Ther. pmid:2425080
Arai M [Plasma thromboxane B2 levels in various liver diseases]. 1986 Nihon Shokakibyo Gakkai Zasshi pmid:3735742
Catapano AL et al. Bile lipids, platelet aggregability and pro-ApoAI processing in 2 cases of Tangier disease. 1986 Monogr Atheroscler pmid:3736556
Semrad SD et al. Hypertension in bulls and steers anesthetized with guaifenesin-thiobarbiturate-halothane combination. 1986 Am. J. Vet. Res. pmid:3740628
Cao QL [Dynamic analysis of plasma TXB2 determined by radioimmunoassay in 30 cases of cerebral infarction]. 1986 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:3743234
Xie P [Clinical significance of TXB2 level in CSF of patients with acute cerebrovascular diseases]. 1986 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:3743244
Flower RJ et al. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. 1986 Br. J. Pharmacol. pmid:3006856
Ishihara Y et al. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs. 1986 Prostaglandins Leukot Med pmid:3457388
Schenkein HA Prostaglandin E and thromboxane B2 release by PMA-induced U937 cells in response to C3b. 1986 J. Leukoc. Biol. pmid:3457882
Kääpä P et al. Increased platelet thromboxane B2 production in newborn infants of diabetic mothers. 1986 Prostaglandins Leukot Med pmid:3458263
Peers SH and Hoult JR Inhibition by ethanol and mepacrine of phospholipase-dependent prostaglandin release from the isolated perfused rat lung. 1986 Eur. J. Pharmacol. pmid:3081357
Kudo K et al. [Urinary excretion of thromboxane B2 in normal human subjects: sex and age differences]. 1986 Nippon Naika Gakkai Zasshi pmid:3746076
Weiner BH et al. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. 1986 N. Engl. J. Med. pmid:3748103
Oei HH et al. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock. 1986 Circ. Shock pmid:3753907
Catella F et al. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3461463
Klotman PE et al. Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. 1986 Am. J. Physiol. pmid:3456211
Miller MJ et al. Compartmental prostaglandin release by angiotensin II and arginine-vasopressin in rabbit isolated perfused kidneys. 1986 Eur. J. Pharmacol. pmid:3456305
Calò L et al. Arachidonic acid metabolites in a nephroblastoma associated with paraneoplastic hypercalcemia. 1986 Prostaglandins pmid:3020618
Turi S et al. Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura. 1986 Arch. Dis. Child. pmid:2420289
Mueller HS et al. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin. 1986 Herz pmid:2939012
Legrand YJ et al. Activation of platelets by microfibrils and collagen. A comparative study. 1986 Lab. Invest. pmid:2939291
Connellan JM et al. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen. 1986 Thromb. Haemost. pmid:2940722
Eldrup-Jorgensen J et al. Antiplatelet therapy and vascular grafts. Studies in a baboon ex vivo shunt. 1986 Arch Surg pmid:2940991
Arai M et al. Platelet dysfunction and alteration of prostaglandin metabolism after chronic alcohol consumption. 1986 Scand. J. Gastroenterol. pmid:3810010
Chiang TM and Kang AH The effect of platelet surface protein phosphorylation on collagen-platelet interaction. 1986 Thromb. Res. pmid:3810565
Perkett EA et al. Lymphocyte and granulocyte migration across the endothelial layer of bovine pulmonary artery intimal explants towards lymphocyte conditioned medium. 1986 Tissue Cell pmid:3810636
Madden MC et al. Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. 1986 Prostaglandins pmid:3094092
Cerletti C et al. Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man. 1986 Agents Actions Suppl. pmid:3101444
Purchase M et al. Physiological concentrations of epinephrine potentiate thromboxane A2 release from platelets in the isolated rat heart. 1986 Circ. Res. pmid:3080260
Tremoli E et al. Dietary interventions in north Karelia, Finland and south Italy. Modification of thromboxane B2 formation in platelets of male subjects only. 1986 Atherosclerosis pmid:3964338
DiBenedetto FE and Bito LZ Transport of prostaglandins and other eicosanoids by the choroid plexus: its characterization and physiological significance. 1986 J. Neurochem. pmid:3517230
Pohanka E and Sinzinger H Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteers. 1986 Prostaglandins Leukot Med pmid:3523540
Masi I et al. Effects of CDP-choline on platelet aggregation and the antiaggregatory activity of arterial wall in the rat. 1986 Pharmacol Res Commun pmid:3523545
Winn R et al. Lung permeability and hemodynamics during endotoxemia: effect of aprotinin. 1986 J. Surg. Res. pmid:2431222